↓ Skip to main content

Dove Medical Press

Anti-VEGF treatment for myopic choroid neovascularization: from molecular characterization to update on clinical application

Overview of attention for article published in Drug Design, Development and Therapy, July 2015
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (54th percentile)
  • Good Attention Score compared to outputs of the same age and source (68th percentile)

Mentioned by

policy
1 policy source

Citations

dimensions_citation
32 Dimensions

Readers on

mendeley
48 Mendeley
Title
Anti-VEGF treatment for myopic choroid neovascularization: from molecular characterization to update on clinical application
Published in
Drug Design, Development and Therapy, July 2015
DOI 10.2147/dddt.s87920
Pubmed ID
Authors

Yan Zhang, Qian Han, Yusha Ru, Qiyu Bo, Rui Hua Wei

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 48 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 48 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 6 13%
Researcher 6 13%
Student > Master 5 10%
Student > Ph. D. Student 5 10%
Student > Postgraduate 4 8%
Other 7 15%
Unknown 15 31%
Readers by discipline Count As %
Medicine and Dentistry 22 46%
Biochemistry, Genetics and Molecular Biology 3 6%
Pharmacology, Toxicology and Pharmaceutical Science 2 4%
Neuroscience 2 4%
Economics, Econometrics and Finance 1 2%
Other 3 6%
Unknown 15 31%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 15 September 2017.
All research outputs
#8,759,452
of 25,837,817 outputs
Outputs from Drug Design, Development and Therapy
#658
of 2,285 outputs
Outputs of similar age
#97,278
of 279,263 outputs
Outputs of similar age from Drug Design, Development and Therapy
#47
of 156 outputs
Altmetric has tracked 25,837,817 research outputs across all sources so far. This one is in the 43rd percentile – i.e., 43% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,285 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.2. This one has gotten more attention than average, scoring higher than 65% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 279,263 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 54% of its contemporaries.
We're also able to compare this research output to 156 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 68% of its contemporaries.